Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Abbott Laboratories (NYSE: ABT) | Delayed: 98.97 -3.48 (3.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.45 | 52 Week High | $46.38 | |||
| Open | $101.31 | 52 Week Low | $36.00 | |||
| Day High | $106.35 | P/E | 65.98 | |||
| Day Low | $97.67 | EPS | $1.50 | |||
| Volume | 16,360,170 | |||||
